369 related articles for article (PubMed ID: 18850378)
1. Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes.
Amini M; Horri N; Farmani M; Haghighi S; Sattari G; Pornaghshband Z; Aminorroaya A
Gynecol Endocrinol; 2008 Aug; 24(8):423-7. PubMed ID: 18850378
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran.
Mirzaei F; Kazemi N
Metab Syndr Relat Disord; 2008 Sep; 6(3):215-7. PubMed ID: 18710333
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.
Indhavivadhana S; Wongwananuruk T; Rattanachaiyanont M; Techatraisak K; Leerasiri P; Tanmahasamut P; Popijan M
J Med Assoc Thai; 2010 Jun; 93(6):653-60. PubMed ID: 20572369
[TBL] [Abstract][Full Text] [Related]
4. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
5. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
6. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome.
Sir-Petermann T; Angel B; Maliqueo M; Carvajal F; Santos JL; Pérez-Bravo F
Diabetologia; 2002 Jul; 45(7):959-64. PubMed ID: 12136394
[TBL] [Abstract][Full Text] [Related]
10. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
11. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome.
Espinós-Gómez JJ; Corcoy R; Calaf J
Gynecol Endocrinol; 2009 Mar; 25(3):199-204. PubMed ID: 19347711
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome].
Benítez R; Sir-Petermann T; Palomino A; Angel B; Maliqueo M; Pérez F; Calvillán M
Rev Med Chil; 2001 Jul; 129(7):707-12. PubMed ID: 11552437
[TBL] [Abstract][Full Text] [Related]
16. To determine whether first-degree male relatives of women with polycystic ovary syndrome are at higher risk of developing cardiovascular disease and type II diabetes mellitus.
Hunter A; Vimplis S; Sharma A; Eid N; Atiomo W
J Obstet Gynaecol; 2007 Aug; 27(6):591-6. PubMed ID: 17896258
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women.
Talbott EO; Zborowski JV; Rager JR; Kip KE; Xu X; Orchard TJ
J Womens Health (Larchmt); 2007 Mar; 16(2):191-7. PubMed ID: 17388735
[TBL] [Abstract][Full Text] [Related]
18. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
Rabelo Acevedo M; Vick MR
P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
[TBL] [Abstract][Full Text] [Related]
19. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and polycystic ovary syndromes in indigenous South Asian women with previous gestational diabetes mellitus.
Wijeyaratne CN; Waduge R; Arandara D; Arasalingam A; Sivasuriam A; Dodampahala SH; Balen AH
BJOG; 2006 Oct; 113(10):1182-7. PubMed ID: 16972862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
